A Bay Area biotech company saw its obesity drug fail in clinical trials just five months ago. Now it's being acquired for nearly $7 billion after shifting its focus to a different disease.

"Employers aren't just looking to fill positions; they're looking for specific skills, delivered fast, with results they can ...

Neither Republican senators, who made the latest offer to end a funding impasse, nor Democrats, who are demanding more ...

As Waymo expands, experts say autonomous cars still struggle with the unpredictability and social norms of real-world driving ...

The Manitoba government has tabled its third budget in the red, projecting a higher-than-expected $1.67-billion deficit, as ...

Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today ...

Staff at the Australian Broadcasting Corporation will strike for the first time in 20 years.

Since 2020, Russia has been expanding its presence in the Sahel region, seizing the initiative from Paris and Washington and enhancing its standing across sub-Saharan Africa. Recognizing that mounting ...

Girlguiding said that while its trans-inclusive values had not changed, it was forced to comply with the U.K. Supreme Court's ...

MP Bradley Thomas has urged residents to use the towns Post Office counter in TG Jones on Bromsgrove High Street after it was ...

Jean Silva says he will leave UFC if Alexander Volkanovski beats him while pushing for a featherweight title fight.

After taking a gamble in seeking a new mandate, Thailand's newly reelected PM Anutin Charnvirakul has cast himself as a force ...